An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations

por Kornek, Barbara
Publicado en Patient Prefer Adherence (2015)

Axonal Pathology in Multiple Sclerosis. A Historical Note

por Kornek, Barbara, Lassmann, Hans
Publicado en Brain Pathol (2006)

Similar impact of multiple sclerosis and migraine on sexual function in women: Is the multiple sclerosis impact scale questionnaire useful?

por Salhofer-Polanyi, Sabine, Wöber, Christian, Prohazka, Ricarda, Dal-Bianco, Assunta, Bajer-Kornek, Barbara, Zebenholzer, Karin
Publicado en Wien Klin Wochenschr (2016)

Exome-Sequence Analyses of Four Multi-Incident Multiple Sclerosis Families

por Zrzavy, Tobias, Leutmezer, Fritz, Kristoferitsch, Wolfgang, Kornek, Barbara, Schneider, Christine, Rommer, Paulus, Berger, Thomas, Zimprich, Alexander
Publicado en Genes (Basel) (2020)

Epidemiology of Pediatric NMOSD in Germany and Austria

por Lechner, Christian, Breu, Markus, Wendel, Eva-Maria, Kornek, Barbara, Schanda, Kathrin, Baumann, Matthias, Reindl, Markus, Rostásy, Kevin
Publicado en Front Neurol (2020)

Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis : A Comparative Quantitative Study of Axonal Injury in Active, Inactive, and Remyelinated Lesions

por Kornek, Barbara, Storch, Maria K., Weissert, Robert, Wallstroem, Erik, Stefferl, Andreas, Olsson, Tomas, Linington, Christopher, Schmidbauer, Manfred, Lassmann, Hans
Publicado 2000

The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study

por Altmann, Patrick, Hinterberger, Werner, Leutmezer, Fritz, Ponleitner, Markus, Monschein, Tobias, Zrzavy, Tobias, Zulehner, Gudrun, Kornek, Barbara, Lanzenberger, Rupert, Berek, Klaus, Rommer, Paulus Stefan, Berger, Thomas, Bsteh, Gabriel
Publicado en JMIR Res Protoc (2021)

Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of th...

por Bertolotto, Antonio, Arroyo, Rafael, Celius, Elisabeth G., Comi, Giancarlo, Havrdova, Eva Kubala, Honeycutt, William David, Hunter, Samuel F., Izquierdo, Guillermo, Kornek, Barbara, Miller, Tamara, Mitsikostas, Dimos D., Singer, Barry A., Ziemssen, Tjalf, Chung, Luke, Daizadeh, Nadia, Afsar, Salman, Hashemi, Lobat, Senior, Peter
Publicado en Neurol Ther (2020)

Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score

por Bsteh, Gabriel, Hegen, Harald, Riedl, Katharina, Altmann, Patrick, Auer, Michael, Berek, Klaus, Di Pauli, Franziska, Ehling, Rainer, Kornek, Barbara, Monschein, Tobias, Rinner, Walter, Schmied, Christiane, Wurth, Sebastian, Zebenholzer, Karin, Zinganell, Anne, Zrzavy, Tobias, Zulehner, Gudrun, Deisenhammer, Florian, Rommer, Paulus, Leutmezer, Fritz, Berger, Thomas
Publicado en Eur J Neurol (2021)

Treatment and outcome of aquaporin-4 antibody–positive NMOSD: A multinational pediatric study

por Paolilo, Renata Barbosa, Hacohen, Yael, Yazbeck, Elise, Armangue, Thais, Bruijstens, Arlette, Lechner, Christian, Apostolos-Pereira, Samira Luisa, Martynenko, Yana, Breu, Markus, de Medeiros Rimkus, Carolina, Wassmer, Evangeline, Baumann, Matthias, Papetti, Laura, Capobianco, Marco, Kornek, Barbara, Rostásy, Kevin, da Paz, José Albino, Ciccarelli, Olga, Lim, Ming, Saiz, Albert, Neuteboom, Rinze, Marignier, Romain, Hemingway, Cheryl, Sato, Douglas Kazutoshi, Deiva, Kumaran
Publicado en Neurol Neuroimmunol Neuroinflamm (2020)